Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK Stock Down 1% Submitted by Anonymous (not verified) on Thu, 04/27/2023 - 18:40 Coinspeaker
Moderna (MRNA) Shares Drop 8% despite Impressive Result from Cancer Vaccine Phase 2 Trial Submitted by Anonymous (not verified) on Tue, 04/18/2023 - 11:20 Coinspeaker
Merck in Advanced Talks to Buy Biotech Company Seagen Submitted by Anonymous (not verified) on Thu, 07/07/2022 - 19:40 Coinspeaker
Merck (MRK) Stock Up 1%, UK Regulator Approves Its COVID-19 Pill Molnupiravir Submitted by Anonymous (not verified) on Thu, 11/04/2021 - 16:35 Coinspeaker
Merck Requests FDA for Authorizing COVID Pill for Emergency Use, MRK Stock Doesn’t Reach Submitted by Anonymous (not verified) on Mon, 10/11/2021 - 15:19 Coinspeaker
Weekly Trading at Wall Street Begins with Correction, Dow Jones Tanks 320 Points Submitted by Anonymous (not verified) on Tue, 10/05/2021 - 12:53 Coinspeaker
Merck (MRK) Stock Up 11% after Announcement of Positive COVID-19 Pill Trial Result Submitted by Anonymous (not verified) on Fri, 10/01/2021 - 18:05 Coinspeaker
Dow’s 5-day Party Ends on Tuesday, Index Tanks 0.7% or 280 Points Submitted by Anonymous (not verified) on Wed, 08/18/2021 - 11:49 Coinspeaker